Cytosorbents Corporation

CTSO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,280$14,131$22,145$52,138
Short-Term Investments$0$0$0$0
Receivables$7,320$6,057$5,665$4,523
Inventory$2,733$3,680$3,462$4,766
Other Curr. Assets$8,271$1,834$2,489$2,872
Total Curr. Assets$21,603$25,703$33,760$64,299
Property Plant & Equip (Net)$20,514$22,115$23,347$18,574
Goodwill$0$0$0$0
Intangibles$3,748$3,907$4,391$4,702
Long-Term Investments$0$1,484$1,734$1,944
Tax Assets$0$3,706$0$0
Other NC Assets$1,507-$3,654$0$0
Total NC Assets$25,768$27,558$29,472$25,220
Other Assets$0$0$0$0
Total Assets$47,372$53,261$63,232$89,519
Liabilities
Payables$3,340$3,802$1,655$2,805
Short-Term Debt$453$2,874$109$571
Tax Payable$0$56$22$786
Deferred Revenue$419$1,381$1,517$1,947
Other Curr. Liab.$5,612$6,433$6,412$7,581
Total Curr. Liab.$9,824$14,546$9,715$13,690
LT Debt$26,440$15,440$18,142$13,251
Deferred Rev, NC$0-$3,706$0$0
Deferred Tax Liab, NC$0$3,706$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$26,440$15,440$18,142$13,251
Other Liabilities$0$0$0$0
Cap. Leases$12,897$13,270$13,142$13,251
Total Liabilities$36,265$29,985$27,857$26,941
Equity
Pref Stock$0$0$0$0
Common Stock$55$54$44$43
Retained Earnings-$304,009-$282,505-$253,998-$221,185
AOCI$4,252$529$2,329$526
Other Equity$310,809$305,197$287,000$283,194
Total Equity$11,107$23,275$35,375$62,578
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$47,372$53,261$63,232$89,519
Net Debt$23,613$4,182-$3,894-$38,316